Covered recipient · General Payments record
JAMES MICHAEL KOZENY
Podiatric Medicine & Surgery Service Providers Podiatrist Foot & Ankle Surgery
General Payments · PY2022–2024
$4,233.69
- Reported across 30 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,633.01 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| MIMEDX Group, Inc. | $675.03 | 7 |
| Kerecis Limited | $455.27 | 2 |
| Integra LifeSciences Corporation | $176.85 | 2 |
| Advanced Oxygen Therapy Inc. | $154.22 | 1 |
| Solventum Corporation | $141.53 | 1 |
| Oak Med, Inc. | $15.93 | 1 |
| Smith & Nephew, Inc. | $14.18 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Advanced Oxygen Therapy Inc. | $154.22 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111764580 | CMS |
| Integra LifeSciences Corporation | $163.22 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140101729 | CMS |
| Integra LifeSciences Corporation | $13.63 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140101725 | CMS |
| Kerecis Limited | $167.66 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120115565 | CMS |
| Kerecis Limited | $287.61 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120105294 | CMS |
| MIMEDX Group, Inc. | $76.00 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140262737 | CMS |
| MIMEDX Group, Inc. | $142.25 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140262739 | CMS |
| MIMEDX Group, Inc. | $42.77 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140262741 | CMS |
| MIMEDX Group, Inc. | $96.83 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140262743 | CMS |
| MIMEDX Group, Inc. | $128.00 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140262745 | CMS |
| MIMEDX Group, Inc. | $100.80 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140262747 | CMS |
| MIMEDX Group, Inc. | $88.38 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140262749 | CMS |
| Oak Med, Inc. | $15.93 | 11/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126532910 | CMS |
| Smith+Nephew, Inc. | $14.18 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149598234 | CMS |
| Solventum Corporation | $141.53 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144090381 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.